The Bethesda System for Reporting Thyroid Cytopathology: A Meta-Analysis
M. Sughayer, Niveen I. Abdullah
2017.2.7Acta Cytologica
Paper details
- Journal
- Acta Cytologica
- Published
- 2017.2.7
- Citations
- 560
- References
- 1
- Fields
- Medicine
tlooto Summary
The rate of 0.5% as shown in Table 5 is derived from considering as false positive only those cases in category VI that were proven benign after surgical excision, which is in obvious contradiction to the stated definitions and calculation methods.
Abstract
results in Table 5 of the paper. All the calculations are accurate and are according to their definitions for a “screening test” except for the false-positive rate, which they calculated as being 0.5%. It is however clear that if they had used their defined groups of false positive and true negative numbers, the false-positive rate would have been a significantly different value of 49.3%! The rate of 0.5% as shown in Table 5 is derived from considering as false positive only those cases in category VI that were proven benign after surgical excision, which is in obvious contradiction to the stated definitions and calculation methods. This very low number is also in sharp contrast to the other indicators, such as specificity, positive predictive value, and diagnostic accuracy, and is a source of confusion to the reader. It may be true that the real false-positive rate as classically used in cytopathology considers only cases interpreted as definitely malignant that turn out to be benign. However, the method of calculation as defined by the authors should be adhered to throughout, unless otherwise specified.
Citation format
SUGHAYER, M.; ABDULLAH, Niveen I. The bethesda system for reporting thyroid cytopathology: A meta-analysis. Acta Cytologica, 2017, 61(2): 172–172.